ALGORAE PHARMACEUTICALS LIMITED — Director's Dealing 2007

Nov 29, 2007

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity LIVING CELL TECHNOLOGIES LTD ABN 104 028 042

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	MR DAVID L BROOKES
Date of last notice	23 AUGUST 2007

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	DIRECT
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.
Date of change	30 NOVEMBER 2007
No. of securities held prior to change	100,000 ORDINARY SHARES (HELD BYDAVID LIONEL BROOKES)335,000 ORDINARY SHARES (HELD BYDR DAVID LIONEL BROOKES & MRSELISABETH BROOKES <DR DL BROOKESPERSONAL SUPERFUND A/C>)50,000 ORDINARY SHARES (HELD BYMRS ELISABETH MARY BROOKES<DAHLBROOK FAMILY A/C>)
Class	UNLISTED OPTIONS
Number acquired	400,000
Number disposed	NIL

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration	NIL ISSUE PRICE
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change	100,000 ORDINARY SHARES (HELD	BY
	DAVID LIONEL BROOKES)
	335,000 ORDINARY SHARES (HELD BY
	DR DAVID LIONEL BROOKES & MRS
	ELISABETH BROOKES <DR DL BROOKES
	PERSONAL SUPERFUND A/C>
	50,000 ORDINARY SHARES (HELD	BY
	MRSELISABETHMARYBROOKES
	<DAHLBROOK FAMILY A/C>
	150,000 OPTIONS – EXERCISABLE	AT
	$0.20 EACH, VESTING 28/08/2008 AND
	EXPIRING 30/11/2012
	250,000 OPTIONS – EXERCISABLE	AT
	$0.30 EACH, VESTING 28/08/2008 AND
	EXPIRING 30/11/2012
Nature of change	ISSUEOFOPTIONSAPPROVED	BY
Example: on-market trade, off-market trade, exercise of options, issue of	SHAREHOLDERS AT THE AGM HELD	ON
securities under dividend reinvestment plan, participation in buy-back	27/11/2007

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to which	N/A
interest related prior to change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Note: If consideration is non-cash, provide details and
an estimated valuation
Interest after change	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002